{"schema_version":"secwatch.filing_event.v1","accession":"0001178913-26-000875","form_type":"8-K","ticker":"LFWD","cik":"0001607962","company_name":"Lifeward Ltd.","filed_at":"2026-03-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.632319+00:00","generated_at":"2026-05-15T12:34:58.372485+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Lifeward shareholders approve Oratech Pharma acquisition and related proposals","bullets":["Proposal 1 passed: issuance of ordinary shares to Oramed for Oratech acquisition (1,854,591 for, 470,084 against).","Proposal 2 passed: election of two external directors contingent on closing of Oratech acquisition.","Proposal 5 passed: equity grant to CEO Mark Grant (1,656,670 for, 674,846 against).","Proposal 6 passed: reappointment of Ernst & Young as auditor for FY 2026 (6,175,644 for)."],"urls":{"canonical":"https://secwatch.observer/filing/0001178913-26-000875","json":"https://secwatch.observer/filing/0001178913-26-000875.json","markdown":"https://secwatch.observer/filing/0001178913-26-000875.md","text":"https://secwatch.observer/filing/0001178913-26-000875.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1607962/000117891326000875/0001178913-26-000875-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1607962/000117891326000875/zk2634572.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T12:34:58.372485+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}